1-4 of 4
Eric Leifer, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Multi-Center Biologic Assignment Trial Comparing Reduced Intensity Allogeneic Hematopoietic Cell Transplantation to Hypomethylating Therapy or Best Supportive Care in Patients Aged 50-75 with Advanced Myelodysplastic Syndrome: Blood and Marrow Transplant Clinical Trials Network Study 1102

Ryotaro Nakamura, MD, Wael Saber, MD MS, Michael J Martens, PhD, Alyssa Ramirez, Bart L. Scott, MD, Betul Oran, MDMS, Eric Leifer, PhD, Roni Tamari, MD, Asmita Mishra, MD, Richard T. Maziarz, MD, Joseph P. McGuirk, DO, Peter Westervelt, MD PhD, Sumithra Vasu, MDMBBS, Mrinal M. Patnaik, MDMBBS, Rammurti Kamble, MD, Stephen J. Forman, MD, Mikkael A. Sekeres, Frederick R. Appelbaum, MD, Adam M. Mendizabal, MS, Brent Logan, PhD, Mary M. Horowitz, MD MS, Corey Cutler, MD MPH, FRCPC
Journal: Blood
Blood (2020) 136 (Supplement 1): 19–21.
https://doi.org/10.1182/blood-2020-136828
Published: 2020
Journal Articles

Results of a Phase III Randomized, Multi-Center Study of Allogeneic Stem Cell Transplantation after High Versus Reduced Intensity Conditioning in Patients with Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML): Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0901

Bart L Scott, MD, Marcelo C. Pasquini, MD, Brent Logan, PhD, Juan Wu, Steve Devine, MD, David L Porter, MD, Richard T. Maziarz, MD, Erica Warlick, MD, Hugo F. Fernandez, M.D., Edwin P. Alyea, MD, Mehdi Hamadani, MD, Asad Bashey, MD, PhD, Sergio A. Giralt, MD, Eric Leifer, PhD, Nancy Geller, PhD, Jennifer Le-Rademacher, PhD, Adam M. Mendizabal, PhD, Mary M. Horowitz, MD, MS, H. Joachim Deeg, MD, Mitchell E. Horwitz, MD
Journal: Blood
Blood (2015) 126 (23): LBA-8.
https://doi.org/10.1182/blood.V126.23.LBA-8.LBA-8
Published: 2015
Journal Articles

Optimized Cyclophosphamide (CY) Dosing in Combination with Fludarabine, TBI and ATG As Conditioning for Unrelated Donor Bone Marrow Transplantation (BMT) in Severe Aplastic Anemia (SAA): A Phase I/II Study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN)

Paolo Anderlini, MD, Juan Wu, MS, H. Joachim Deeg, MD, Iris Gersten, MS, Marian Ewell, ScD, Jakub Tolar, MD PhD, Joseph H. Antin, MD, Sally Arai, MD, Mitchell E. Horwitz, MD, John M. McCarty, MD, Ryotaro Nakamura, MD, Michael A. Pulsipher, MD, Roberta H. Adams, MD, Eric Leifer, PhD, Shelly L Carter, ScD, Nancy L DiFronzo, PhD, Mary M. Horowitz, MD MS, Dennis L. Confer, MD, Mary Eapen, MBBS, MS
Journal: Blood
Blood (2014) 124 (21): 541.
https://doi.org/10.1182/blood.V124.21.541.541
Published: 2014
Journal Articles

Fludarabine-Based Conditioning for Allogeneic Marrow Transplantation From Unrelated Donors in Severe Aplastic Anemia (SAA): Serious and Unexpected Adverse Events in Pre-Defined Cyclophosphamide (CY) Dose Levels

Jakub Tolar, MD, PhD, H. Joachim Deeg, M.D., Sally Arai, MD, Mitchell Horwitz, MD, Joseph H. Antin, MD, John M. McCarty, MD, Roberta H. Adams, MD, Mary Eapen, MBBS, Marian Ewell, ScD, Eric Leifer, PhD, Iris Gersten, MS, Shelly L Carter, ScD, Mary M. Horowitz, MD, Dennis L Confer, MD, Ryotaro Nakamura, MD, Michael Pulsipher, MD, Nancy L DiFronzo, PhD, Paolo Anderlini, MD
Journal: Blood
Blood (2011) 118 (21): 3009.
https://doi.org/10.1182/blood.V118.21.3009.3009
Published: 2011